Effects of Physical Training on Bone Turnover and Quality of Life in Osteopenic Postmenopausal Women.
Effects of a 3-month Weight-bearing and Resistance Exercise Training on Circulating Osteoprogenitor Cells and Bone Formation Markers in Postmenopausal Women With Low Bone Mass.
1 other identifier
interventional
33
0 countries
N/A
Brief Summary
The aim of our research was to define both in vivo and in vitro whether and to what extent an high-impact exercise program would affect bone cell turnover and improve the QoL in osteopenic postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 15, 2017
CompletedFirst Posted
Study publicly available on registry
June 22, 2017
CompletedResults Posted
Study results publicly available
February 11, 2019
CompletedFebruary 11, 2019
September 1, 2018
10 months
June 15, 2017
October 31, 2017
September 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Variation in Serum Levels of Procollagen 1 N-terminal Peptide (P1NP)
P1NP is the most reliable serum marker of bone formation commercially available at the moment
Baseline - Week 4
Variation in Serum Levels of Procollagen 1 N-terminal Peptide (P1NP).
P1NP is the most reliable serum marker of bone formation, commercially available at the moment.
Week 4 - Week 12
Serum Sclerotin Levels
Sclerostin has been proposed as the check-point where physical activity (PA) acts to modulate bone metabolism.
Baseline - W4
Sclerostin
Sclerostin has been proposed as the check-point where PA acts to modulate bone metabolism.
Week 4 - Week 12
Variation in Serum Carboxy-terminal Telopeptide of Collagen Type I (sCTX)
Serum carboxy-terminal telopeptide of collagen type I (sCTX) is one of the most sensitive and specific bone resorption markers of osteoclast-mediated collagen degradation
Baseline - Week 4
Variation of Serum Carboxy Terminal Telopeptide of Collagen Type I (sCTX)
Serum carboxy terminal telopeptide of collagen type I (sCTX) is one of the most sensitive and specific bone resorption markers of osteoclast-mediated collagen degradation.
Week 4 - Week 12
Variation in Circulating Osteoprogenitor Cells (OPCs)
Measurements of circulating OPCs with stem cell characteristics (CD34+) and express bone-specific proteins such as alkaline phosphatase (AP +) and osteocalcin (OCN +).
Baseline - Week 4
Variation in Circulating Osteoprogenitor Cells (OPCs).
Measurements of circulating OPCs with stem cell characteristics (CD34+) and express bone-specific proteins such as alkaline phosphatase (AP +) and osteocalcin (OCN +).
Week 4 - Week 12
Secondary Outcomes (2)
Variation in Health-related Quality of Life (QoL)
Baseline - Week 4
Variation in Health-related Quality of Life (QoL).
Week 4 - Week 12
Study Arms (2)
Physical Exercise
EXPERIMENTALThe exercise program was performed at C.U.R.I.A.Mo. Institute of "UniversitĂ degli Studi di Perugia". Twenty-four exercise sessions were provided, carried out twice a week for three months. Each session was supervised by two graduated trainers and two medical doctors with a maximum attendance of 5 patient/group. Each session lasted 45 minutes divided into 15 minutes of aerobic activity and 30 minutes of weight-bearing and resistance activities. This latter section was specifically projected for adults and older adults with increased risk of fractures and was intended to improve muscle strength and flexibility, balance and, as a result, to prevent the risk of falls.
No additional physical exercise
NO INTERVENTIONUsual recommendations for prevention of fractures in adults and elderly.
Interventions
Eligibility Criteria
You may qualify if:
- postmenopausal
- bone mineral density T-score less than -1 but more than -2.5 in the total hip or lumbar spine (L1-L4) by dual energy x-ray absorptiometry
- be able to attend an exercise program 2 times per week over the 3-month period
- stated availability throughout the entire study period
You may not qualify if:
- secondary causes of bone loss such as osteomalacia, glucocorticoid medication
- co-morbidities that would interfere with participation in exercise such as severe heart or pulmonary disease, inflammatory joint disease, severe osteoarthritis, psychiatric condition
- physical or orthopaedic disabilities that would place the subject at risk or limit their ability to perform exercise
- a past vertebral fracture
- history of chronic diseases, such as renal, hepatic, cardiac, and rheumatic diseases
- current or prior use of drugs that could interfere with bone mass (i.e. glucocorticoids, antiresorptive drugs and hormonal replacement therapy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (9)
Turner CH, Robling AG. Mechanisms by which exercise improves bone strength. J Bone Miner Metab. 2005;23 Suppl:16-22. doi: 10.1007/BF03026318.
PMID: 15984409BACKGROUNDPasqualini L, Leli C, Ministrini S, Schillaci G, Zappavigna RM, Lombardini R, Scarponi AM, Mannarino E. Relationships between global physical activity and bone mineral density in a group of male and female students. J Sports Med Phys Fitness. 2017 Mar;57(3):238-243. doi: 10.23736/S0022-4707.16.06054-0. Epub 2016 May 31.
PMID: 27244129BACKGROUNDMartyn-St James M, Carroll S. A meta-analysis of impact exercise on postmenopausal bone loss: the case for mixed loading exercise programmes. Br J Sports Med. 2009 Dec;43(12):898-908. doi: 10.1136/bjsm.2008.052704. Epub 2008 Nov 3.
PMID: 18981037BACKGROUNDRobling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2008 Feb 29;283(9):5866-75. doi: 10.1074/jbc.M705092200. Epub 2007 Dec 17.
PMID: 18089564BACKGROUNDLi WC, Chen YC, Yang RS, Tsauo JY. Effects of exercise programmes on quality of life in osteoporotic and osteopenic postmenopausal women: a systematic review and meta-analysis. Clin Rehabil. 2009 Oct;23(10):888-96. doi: 10.1177/0269215509339002. Epub 2009 Aug 28.
PMID: 19717503BACKGROUNDPirro M, Leli C, Fabbriciani G, Manfredelli MR, Callarelli L, Bagaglia F, Scarponi AM, Mannarino E. Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis. Osteoporos Int. 2010 Feb;21(2):297-306. doi: 10.1007/s00198-009-0968-0. Epub 2009 May 30.
PMID: 19484167BACKGROUNDLips P, Leplege A (2000). Development and validation of quality of life questionnaire for patients with vertebral fractures: Qualeffo-41. Quality of Life Research 9(6a):763-766.
BACKGROUNDAdami S, Gatti D, Viapiana O, Fiore CE, Nuti R, Luisetto G, Ponte M, Rossini M; BONTURNO Study Group. Physical activity and bone turnover markers: a cross-sectional and a longitudinal study. Calcif Tissue Int. 2008 Dec;83(6):388-92. doi: 10.1007/s00223-008-9184-8. Epub 2008 Oct 24.
PMID: 18949504BACKGROUNDPasqualini L, Ministrini S, Lombardini R, Bagaglia F, Paltriccia R, Pippi R, Collebrusco L, Reginato E, Sbroma Tomaro E, Marini E, D'Abbondanza M, Scarponi AM, De Feo P, Pirro M. Effects of a 3-month weight-bearing and resistance exercise training on circulating osteogenic cells and bone formation markers in postmenopausal women with low bone mass. Osteoporos Int. 2019 Apr;30(4):797-806. doi: 10.1007/s00198-019-04908-9. Epub 2019 Feb 26.
PMID: 30809725DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Short duration of the observation (12 weeks). Small number of the sample. We did not provide any confirmation of the effects of the exercise program in terms of bone mineral density (BMD) or fracture risk.
Results Point of Contact
- Title
- Dr. Rita Lombardini
- Organization
- University of Perugia - Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Lombardini
University Of Perugia
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 15, 2017
First Posted
June 22, 2017
Study Start
May 1, 2015
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
February 11, 2019
Results First Posted
February 11, 2019
Record last verified: 2018-09